Search alternatives:
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
mean decrease » a decrease (Expand Search)
Showing 13,201 - 13,220 results of 52,235 for search '(( a ((mean decrease) OR (linear decrease)) ) OR ( a ((largest decrease) OR (larger decrease)) ))', query time: 0.98s Refine Results
  1. 13201

    Acceptance of the HPV vaccine. by Mohammad Delwer Hossain Hawlader (11558838)

    Published 2024
    “…After adjustment for other factors, it was found that higher age was associated with a decreased acceptance (AOR: 0.92; 95% CI: 0.89–0.95). …”
  2. 13202

    Cues to the action question. by Mohammad Delwer Hossain Hawlader (11558838)

    Published 2024
    “…After adjustment for other factors, it was found that higher age was associated with a decreased acceptance (AOR: 0.92; 95% CI: 0.89–0.95). …”
  3. 13203

    Characteristics of the respondents (n = 2,151). by Mohammad Delwer Hossain Hawlader (11558838)

    Published 2024
    “…After adjustment for other factors, it was found that higher age was associated with a decreased acceptance (AOR: 0.92; 95% CI: 0.89–0.95). …”
  4. 13204

    Determinants of HPV vaccine acceptance. by Mohammad Delwer Hossain Hawlader (11558838)

    Published 2024
    “…After adjustment for other factors, it was found that higher age was associated with a decreased acceptance (AOR: 0.92; 95% CI: 0.89–0.95). …”
  5. 13205
  6. 13206
  7. 13207
  8. 13208

    Blood Pressure and LDL-C During Follow-up. by Karl Ingard (22582091)

    Published 2025
    “…The secondary endpoints were cardiovascular death, myocardial infarction, stroke, ischemic stroke, all-cause mortality, fracture, orthostatic hypotension, serious bleeding, and health-related quality of life. During a mean follow-up of 3.8 years, 31.7% (n = 64) of the patients in the intervention group and 37.5% (n = 72) in the control group reached the primary endpoint (HR 0.82, 95% CI 0.58–1.14, <i>P</i> = 0.23). …”
  9. 13209

    Baseline Characteristics of Included Patients. by Karl Ingard (22582091)

    Published 2025
    “…The secondary endpoints were cardiovascular death, myocardial infarction, stroke, ischemic stroke, all-cause mortality, fracture, orthostatic hypotension, serious bleeding, and health-related quality of life. During a mean follow-up of 3.8 years, 31.7% (n = 64) of the patients in the intervention group and 37.5% (n = 72) in the control group reached the primary endpoint (HR 0.82, 95% CI 0.58–1.14, <i>P</i> = 0.23). …”
  10. 13210

    Predictive validity. by Roberta Maria Lorenzi (16920886)

    Published 2023
    “…Quantitative score normalized to baseline (w = 100% in blue). <b>A) MLI-PC feed forward inhibition</b>. The change of total activity (measured as Area Under Curve (AUC)) and the initial peak amplitude decrease exponentially with the MLI-PC strength. …”
  11. 13211
  12. 13212
  13. 13213
  14. 13214
  15. 13215
  16. 13216
  17. 13217
  18. 13218
  19. 13219
  20. 13220